Clinical trial
Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
NCT00487214 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- February 28, 2003
- Enrollment
- 361 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.